| BRAF mutation in papillary thyroid carcinoma Y Cohen, M Xing, E Mambo, Z Guo, G Wu, B Trink, U Beller, WH Westra, ... Journal of the National Cancer Institute 95 (8), 625-627, 2003 | 1155 | 2003 |
| ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development G Wu, S Nomoto, MO Hoque, T Dracheva, M Osada, CCR Lee, SM Dong, ... Cancer research 63 (10), 2351-2357, 2003 | 322 | 2003 |
| Somatic mutation and gain of copy number of PIK3CA in human breast cancer G Wu, M Xing, E Mambo, X Huang, J Liu, Z Guo, A Chatterjee, ... Breast cancer research 7, 1-8, 2005 | 292 | 2005 |
| Uncommon Mutation, but Common Amplifications, of the PIK3CA Gene in Thyroid Tumors G Wu, E Mambo, Z Guo, S Hu, X Huang, SM Gollin, B Trink, PW Ladenson, ... The Journal of Clinical Endocrinology & Metabolism 90 (8), 4688-4693, 2005 | 258 | 2005 |
| Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma MS Kim, X Chang, K Yamashita, JK Nagpal, JH Baek, G Wu, B Trink, ... Oncogene 27 (25), 3624-3634, 2008 | 243 | 2008 |
| Forkhead transcription factor foxq1 promotes epithelial–mesenchymal transition and breast cancer metastasis H Zhang, F Meng, G Liu, B Zhang, J Zhu, F Wu, SP Ethier, F Miller, G Wu Cancer research 71 (4), 1292-1301, 2011 | 223 | 2011 |
| Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck S Zhou, S Kachhap, W Sun, G Wu, A Chuang, L Poeta, L Grumbine, ... Proceedings of the National Academy of Sciences 104 (18), 7540-7545, 2007 | 223 | 2007 |
| Differential recognition of response elements determines target gene specificity Forp53 and P63 M Osada, HL Park, Y Nagakawa, K Yamashita, A Fomenkov, MS Kim, ... Molecular and cellular biology 25 (14), 6077-6089, 2005 | 188 | 2005 |
| ΔNp63α up-regulates the Hsp70 gene in human cancer G Wu, M Osada, Z Guo, A Fomenkov, S Begum, M Zhao, S Upadhyay, ... Cancer Research 65 (3), 758-766, 2005 | 171 | 2005 |
| BRAF T1796A Transversion Mutation in Various Thyroid Neoplasms M Xing, V Vasko, G Tallini, A Larin, G Wu, R Udelsman, MD Ringel, ... The Journal of Clinical Endocrinology & Metabolism 89 (3), 1365-1368, 2004 | 167 | 2004 |
| Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma X Liu, G Wu, Y Shan, C Hartmann, A Von Deimling, M Xing Cell cycle 12 (10), 1637-1638, 2013 | 164 | 2013 |
| High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph Nodes V Vasko, S Hu, G Wu, JC Xing, A Larin, V Savchenko, B Trink, M Xing The Journal of Clinical Endocrinology & Metabolism 90 (9), 5265-5269, 2005 | 156 | 2005 |
| Localization of PS6K to Chromosomal Region 17q23 and Determination of Its Amplification in Breast Cancer FJ Couch, XY Wang, GJ Wu, J Qian, RB Jenkins, CD James Cancer research 59 (7), 1408-1411, 1999 | 142 | 1999 |
| LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer G Wu, Z Guo, X Chang, MS Kim, JK Nagpal, J Liu, JM Maki, KI Kivirikko, ... Cancer research 67 (9), 4123-4129, 2007 | 138 | 2007 |
| The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasis F Meng, G Wu Cancer and Metastasis Reviews 31, 455-467, 2012 | 133 | 2012 |
| 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes GJ Wu, CS Sinclair, J Paape, JN Ingle, PC Roche, CD James, FJ Couch Cancer research 60 (19), 5371-5375, 2000 | 121 | 2000 |
| Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of … D Liu, P Hou, Z Liu, G Wu, M Xing Cancer research 69 (18), 7311-7319, 2009 | 118 | 2009 |
| Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo H Zhang, D Chen, J Ringler, W Chen, QC Cui, SP Ethier, QP Dou, G Wu Cancer research 70 (10), 3996-4004, 2010 | 116 | 2010 |
| CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer Z Guo, JF Linn, G Wu, SL Anzick, CF Eisenberger, S Halachmi, Y Cohen, ... Nature medicine 10 (4), 374-381, 2004 | 102 | 2004 |
| A p53-type response element in the GDF15 promoter confers high specificity for p53 activation M Osada, HL Park, MJ Park, JW Liu, G Wu, B Trink, D Sidransky Biochemical and biophysical research communications 354 (4), 913-918, 2007 | 93 | 2007 |
Stephen EthierMedical University of South CarolinaVerified email at musc.edu
